Active ingredients: tiotropium
What it is used for
SRIVASSO is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (COPD). SRIVASSO is indicated for the prevention of COPD exacerbations.
How to take it
The way to take this medicine is: Inhalation.
- Store below 25 degrees Celsius
- Protect from direct sunlight
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Light green, opaque hard gelatin capsules containing a white powder, with product code (TI 01) and company logo printed in black on the capsule.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient tiotropium
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems